- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Overview
This bill seeks to withdraw FDA approval for mifepristone (a chemical abortion drug) and create federal liability for harm caused by it, effectively restricting access to medication abortion nationwide.
Law Today
Federal law currently permits mifepristone (a chemical abortion drug) to be approved and distributed under the Federal Food, Drug, and Cosmetic Act for terminating pregnancy.
If Passed
This bill would invalidate the federal approval of mifepristone, effectively banning its use for abortion nationwide, and would create a new federal tort (civil lawsuit) allowing women harmed by chemical abortion drugs to sue. Christian families who believe abortion is morally wrong would see legal barriers to the procedure increased, while families relying on that drug for medical care would face restrictions.
AI-generated from the bill text — verify against the official text.
Should I support this?
- Strongly Oppose
- Likely Oppose
- Neutral
- This billLikely Support
- Strongly Support
Likely Support
From the perspective of Christian families who hold pro-life convictions, this bill would strengthen legal protections for unborn life by eliminating access to a major method of abortion. It aligns with the belief that the sanctity of life should be legally defended from conception, though it does not address all abortion methods and may raise questions about exceptional medical circumstances.
AI assessment using F3’s editorial criteria — faith, family, and freedom. This is F3’s policy judgment; verify the provisions in the official bill text.
Likely supporters & opponents
Likely support
- Pro-life advocacy organizations — Chemical abortion drugs end human life and pose health risks to women; removing federal approval protects both unborn children and maternal safety.
- Religious organizations emphasizing sanctity of life — Mifepristone use directly contradicts the belief that human life begins at conception and should be legally protected.
Likely opposition
- Pro-choice advocacy organizations — This bill strips women of autonomy over their own medical care and pregnancy decisions.
- Medical and reproductive-health organizations — Mifepristone is a safe, FDA-approved medication; revoking approval contradicts medical evidence and restricts physicians' ability to offer standard care.
AI-inferred typical positions based on the bill’s substance — general stakeholder categories, not confirmed endorsements.
Official summary
To provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.
Sponsors
- Diana Harshbarger (R)
- John Rose (R)
- Neal Dunn (R)
- Mark Alford (R)
- Sheri Biggs (R)
- Tracey Mann (R)
- Christopher Smith (R)
- Mary Miller (R)
- Greg Steube (R)
- Ralph Norman (R)
- Roger Williams (R)
- Andrew Clyde (R)
Status timeline
- 2026-03-12Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.H
- 2026-03-12Introduced in HouseH
H = House · S = Senate · A = Assembly